Avadel Pharmaceuticals PLC (AVDL) — Strategic Asset Allocation Index
Avadel Pharmaceuticals PLC (AVDL) has a Strategic Asset Allocation Index of 8.4% as of June 2023. Strategic assets (PP&E of $12.05 Million plus long-term investments of $-) total $12.05 Million, measured against net assets of $143.19 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Avadel Pharmaceuticals PLC Strategic Asset Allocation Index (2000–2021)
This chart shows how Avadel Pharmaceuticals PLC's Strategic Asset Allocation Index has evolved across 20 annual periods from 2000 to 2021. As of June 2023, the index stands at 8.4%, representing strategic assets of $12.05 Million against net assets of $143.19 Million USD. Explore Avadel Pharmaceuticals PLC cash conversion from operations to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Avadel Pharmaceuticals PLC (2000–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Avadel Pharmaceuticals PLC from 2000 to 2021, covering 20 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see AVDL stock market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.4% | $285.00K | $285.00K | $- | $78.24 Million | ▲ +0.1 pp |
| 2020 | 0.2% | $359.00K | $359.00K | $- | $162.27 Million | ▼ -68.5 pp |
| 2018 | 68.7% | $1.91 Million | $1.91 Million | $- | $2.78 Million | ▲ +65.2 pp |
| 2017 | 3.5% | $3.00 Million | $3.00 Million | $- | $84.56 Million | ▼ -4.3 pp |
| 2016 | 7.9% | $3.32 Million | $3.32 Million | $- | $42.07 Million | ▲ +4.0 pp |
| 2015 | 3.9% | $2.62 Million | $2.62 Million | $- | $67.86 Million | ▼ -3.3 pp |
| 2014 | 7.1% | $1.78 Million | $1.78 Million | $- | $24.89 Million | ▼ -52.7 pp |
| 2012 | 59.8% | $18.24 Million | $18.24 Million | $- | $30.50 Million | ▼ -5.3 pp |
| 2011 | 65.1% | $19.38 Million | $19.38 Million | $- | $29.79 Million | ▲ +6.0 pp |
| 2010 | 59.0% | $21.43 Million | $21.43 Million | $- | $36.30 Million | ▲ +3.8 pp |
| 2009 | 55.2% | $24.76 Million | $24.76 Million | $- | $44.86 Million | ▼ -1.7 pp |
| 2008 | 56.9% | $27.60 Million | $27.60 Million | $- | $48.55 Million | ▼ -7.5 pp |
| 2007 | 64.3% | $35.14 Million | $35.14 Million | $- | $54.63 Million | ▲ +29.1 pp |
| 2006 | 35.2% | $25.70 Million | $25.70 Million | $- | $73.03 Million | ▲ +9.4 pp |
| 2005 | 25.8% | $22.32 Million | $22.32 Million | $- | $86.65 Million | ▲ +10.2 pp |
| 2004 | 15.6% | $18.16 Million | $18.16 Million | $- | $116.76 Million | ▲ +10.0 pp |
| 2003 | 5.5% | $5.08 Million | $5.08 Million | $- | $92.06 Million | ▼ -22.2 pp |
| 2002 | 27.7% | $3.40 Million | $3.40 Million | $- | $12.29 Million | ▼ -7.9 pp |
| 2001 | 35.6% | $2.67 Million | $2.67 Million | $- | $7.51 Million | ▲ +8.7 pp |
| 2000 | 26.9% | $2.92 Million | $2.92 Million | $- | $10.88 Million | — |